CIK 0001062822 · Non-accelerated filer<br>Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 760474169
- Phone
- 2818633000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-28 | DeFrancesco Lisa SVP, IR and Corp Comm | Option exercise · Restricted Stock Units | −128,190 | 256,380 | ||
| 2026-02-28 | Crum Brian T SVP, General Counsel & Secr. | Option exercise | +33,457 | 363,658 | ||
| 2026-02-28 | Crum Brian T SVP, General Counsel & Secr. | Option exercise | +69,386 | 330,201 | ||
| 2026-02-28 | Crum Brian T SVP, General Counsel & Secr. | Option exercise | +170,163 | 533,821 | ||
| 2026-02-28 | Crum Brian T SVP, General Counsel & Secr. | Shares withheld for taxes | −105,019 | $1.47 | $154K | 428,802 |
| 2026-02-28 | Crum Brian T SVP, General Counsel & Secr. | Option exercise · Restricted Stock Units | −69,386 | 69,387 | ||
| 2026-02-28 | Crum Brian T SVP, General Counsel & Secr. | Option exercise · Restricted Stock Units | −33,457 | 0 | ||
| 2026-02-28 | Crum Brian T SVP, General Counsel & Secr. | Option exercise · Restricted Stock Units | −170,163 | 340,327 | ||
| 2026-02-28 | Coiante Scott M SVP, Chief Financial Officer | Option exercise | +160,237 | 160,237 | ||
| 2026-02-28 | Coiante Scott M SVP, Chief Financial Officer | Shares withheld for taxes | −54,881 | $1.47 | $81K | 105,356 |
| 2026-02-28 | Coiante Scott M SVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −160,237 | 320,473 | ||
| 2026-02-28 | Exton Michael Chief Executive Officer | Option exercise | +503,263 | 503,263 | ||
| 2026-02-28 | Exton Michael Chief Executive Officer | Shares withheld for taxes | −204,831 | $1.47 | $301K | 298,432 |
| 2026-02-28 | Exton Michael Chief Executive Officer | Option exercise · Restricted Stock Units | −503,263 | 1,006,527 | ||
| 2026-02-25 | DEBBANE RAYMOND Director | Purchase | +2,000 | $1.49 | $3K | 1,906,186 |
| 2026-02-23 | DEBBANE RAYMOND Director | Purchase | +100,000 | $1.47 | $147K | 1,904,186 |
| 2026-02-20 | DEBBANE RAYMOND Director | Purchase | +100,000 | $1.48 | $148K | 1,804,186 |
| 2026-02-19 | DEBBANE RAYMOND Director | Purchase | +50,000 | $1.44 | $72K | 1,704,186 |
| 2026-02-18 | DEBBANE RAYMOND Director | Purchase | +133,688 | $1.32 | $176K | 1,654,186 |
| 2026-02-17 | Artal Participations S.a r.l. Director | Grant or award | +41,289.58 | $65.00 | $2.7M | 408,434.7 |
Page 4 of 15 · 285 trades